Company / Total Assets
Krystal Biotech, Inc. Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$1.3B
FY2025
5-year range
$558.5M / $1.3B
FY2021-FY2025
Trend
+26.3%
vs FY2024
Sector context
#62 of 214
Health Care
What the data says
At $1.3B, Krystal Biotech, Inc.'s total assets ranks #62 of 214 in the Health Care sector. Total Assets has increased for 3 consecutive years, from $558M in FY2022 to $1.3B in FY2025.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +33.8%.
Improved from $818M to $1.3B over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +33.7%
- 5-Year CAGR
- +33.8%
- 10-Year CAGR
- -
Sector benchmark
#62 of 214 in Health CareTop 29% of 214This company $1.3B Sector average $7.5B
▼
-82.1% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s total assets has grown for 3 consecutive years.
- 5-year CAGR of +33.8%, indicating consistent growth.
- In FY2025, total assets increased 26.3% year-over-year.
- Ranks #62 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +26.3% |
| FY2024 | $1.1B | +29.0% |
| FY2023 | $818.4M | +46.5% |
| FY2022 | $558.5M | -10.8% |
| FY2021 | $626.3M | +101.5% |
| FY2020 | $310.8M | +48.7% |
| FY2019 | $209.0M | +80.0% |
| FY2018 | $116.1M | +131.7% |
| FY2017 | $50.1M | +2196.7% |
| FY2016 | $2.2M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026